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Ion channelThe plasmamembrane in eukaryotic cells containsmicrodomains that are enriched in certain glycosphingolipids,
gangliosides, and sterols (such as cholesterol) to form membrane/lipid rafts (MLR). These regions exist as
caveolae, morphologically observable ﬂask-like invaginations, or as a less easily detectable planar form. MLR
are scaffolds for many molecular entities, including signaling receptors and ion channels that communicate
extracellular stimuli to the intracellularmilieu.Much evidence indicates that this organization and/or the cluster-
ing of MLR into more active signaling platforms depends upon interactions with and dynamic rearrangement of
the cytoskeleton. Several cytoskeletal components and binding partners, as well as enzymes that regulate the
cytoskeleton, localize to MLR and help regulate lateral diffusion of membrane proteins and lipids in response
to extracellular events (e.g., receptor activation, shear stress, electrical conductance, and nutrient demand).
MLR regulate cellular polarity, adherence to the extracellular matrix, signaling events (including ones that affect
growth andmigration), and are sites of cellular entry of certain pathogens, toxins and nanoparticles. The dynamic
interaction between MLR and the underlying cytoskeleton thus regulates many facets of the function of eukary-
otic cells and their adaptation to changing environments. Here, we review general features of MLR and caveolae
and their role in several aspects of cellular function, including polarity of endothelial and epithelial cells, cell
migration,mechanotransduction, lymphocyte activation, neuronal growth and signaling, and a variety of disease
settings. This article is part of a Special Issue entitled: Reciprocal inﬂuences between cell cytoskeleton andmem-
brane channels, receptors and transporters. Guest Editor: Jean Claude Hervé.
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The plasma membrane is a dynamic entity. It is both a barrier that
separates the extracellular and intracellular environments and a struc-
ture composed of proteins and lipids that controls and is controlled by
many biological processes. Hydrophobic moieties of lipids self-associate
while their hydrophilic regions interact with the aqueous environment
(in both the extracellular and intracellular milieus) to create the physical
basis of the plasmamembrane bilayer [1,2]. This amphipathicity of lipids
is essential for separating internal cellular structures from the external
environment. Eukaryotic plasma membranes are composed of glycero-
phospholipids, sphingolipids, and sterols (in particular, cholesterol).
The head group of the glycerophospholipids varies, as can the length
and degree of saturation of the associated fatty acyl chains. Sphingolipids
also vary in their ceramide backbones and the N500 different carbohy-
drate structures in the head groups. The introduction of cholesterol to
the plasma membrane appears to have occurred later in evolution than
that of certain othermembrane lipids; its presence coincideswith the in-
crease in environmental oxygen concentration that occurred ~2.5 billion
years ago [3]. The presence of sphingolipids and sterols increases the
complexity of eukaryotic membranes and distinguishes them from the
membranes of prokaryotes. Cholesterol increases the thickness and
stiffness of lipid bilayers [4] and allows for protein sorting [5]. The hydro-
phobic effect of the amphipathic molecules on lipid shapes (i.e., inverted
cones, cylindrical, or conical) forms lamellar, micellar, or cubic supramo-
lecular structures. Certain lipids of eukaryotic cells are not cylindrical and
therefore not predicted to support the formation of a membrane
(lamellar) bilayer; however, the inclusion of proteins in membranes
results in macromolecular assemblies and bilayer asymmetries that
help promote the formation of the lamellar membrane bilayer.
Forty years ago Singer and Nicolson described the plasmamembrane
(PM) as having a ‘ﬂuid mosaic’ environment that randomly partitions
proteins and lipids so as to achieve the lowest free energy [6]. Substantial
subsequent evidence has revealed that this partitioning of proteins is not
homogenous and random but instead consists of clusters of structural
proteins (e.g., integrins and intracellular scaffolds), enzymes, signaling
receptors, transporters and channels within lipid domains; some of
these lipid domains are enriched in cholesterol and certain saturated
acyl lipids and are termed lipid or membrane rafts [7–11]. These mem-
brane domains and their unique protein and lipid content are critical
for many cellular functions. Along with clathrin-coated pits, mem-
brane/lipid rafts (MLR) are structurally and functionally distinct, impor-
tant regions of the PM [10].
There are two major types of MLR: those that contain the choles-
terol binding protein caveolin (Cav) and those that do not. Cav-
containing MLR form morphologically distinct entities, caveolae
(“little caves”), ﬂask-like invaginations of the PM (detectable at
the resolution of electron microscopy) while MLR that lack Cav are
ﬂat and not identiﬁable by electron microscopy. However, some
cells, such as neurons and lymphocytes, that express Cav and con-
tain lipid rafts do not have morphologically identiﬁable invaginated
structures [12]. It remains unclear why such cells express Cav but do
not form caveolae.Interactions betweenMLRand cytoskeletal components can contrib-
ute to the regulation of MLR assembly/clustering and cytoskeletal
dynamics [13,14]. Although the association between cytoskeletal com-
ponents and MLR/caveolae had been previously described [15,16],
recent evidence has extended the notion that cytoskeletal components
(e.g., actin, tubulin, vinculin, ﬁlamin, and tau) [17,18] can localize to
MLR and be platforms for cytoskeletal tethering and for communication
to the extracellular matrix (ECM) via integrins, cadherins, occludins,
and other cellular adhesion molecules (CAMs). Moreover, MLR can
cluster and this clusteringmay depend upon cholesterol and actin teth-
ering to themembrane [19]. Kusumi and colleagues proposed a ‘picket-
fence’model, whereby actin ﬁlaments anchored to MLR regulate lateral
diffusion of membrane proteins and lipids [20,21]. This transient
anchoring of transmembrane proteinswith actin ﬁlamentswas hypoth-
esized to resemble a row of ‘pickets’ that regulate (slow) diffusion of
adjacent proteins and lipids. Based on their additional work, Kusumi
and colleagues have proposed that the transient ‘clustering’ or coalesc-
ing of homodimer rafts forms hetero- and homo-GPI-anchored protein
oligomeric rafts, within the inner leaﬂet, through raft-based lipid inter-
actions that generate functional raft domains [22,23]. Gowrishankar
et al. have demonstrated that this nanomicrodomain clusteringdepends
upon cholesterol, sphingolipids and an active cortical actin meshwork
[24]. These actin meshwork “snippets” are composed of 250 nm actin
ﬁlaments cross-linked by myosin motors that facilitate lateral move-
ment of GPI-anchored proteins in an energy-dependent manner. The
combination of lateral membrane movement and transmembrane
interaction among integrins, membrane bilayer lipids, and membrane
proteins within MLR, along with interaction of the actin/myosin cyto-
skeleton and cytoskeletal tethering partners, can contribute to cellular
migration,mechanotransduction, cell growth, endothelial and epithelial
barrier formation, and immune cell activation—physiologically impor-
tant responses and ones that can be altered in disease settings.
MLR thus serve as regulators of numerous cellular events, including:
1) cellular polarity and organization of trafﬁcking and sorting mecha-
nisms, 2) formation of platforms for ECM adhesion and intracellular cy-
toskeletal tethering to the PM (intracellular–extracellular skeletal
linkage, in particular via integrins, and lateral membrane clustering),
and 3) transduction of signaling cascades across the PM (“outside–in”
signaling), which in turn can rearrange cytoskeletal architecture and
alter cell growth, migration, and other functions and 4) entry of viruses,
bacteria, toxins and nanoparticles. The remainder of this review focuses
onMLR–cytoskeletal interactions that inﬂuence signaling receptors and
channels within the PM and emphasizes articles published in the past
5 years (Table 1).
1.1. Methods for the isolation and enrichment of raft domains
A subset of MLR, termed caveolae were ﬁrst observedmicroscopically
by Palade and Yamada [25,26], however the concept of lipid domainswas
formalized by Karnovsky et al. [27]. These domains were subsequently
termed glycolipid-enriched membranes by Parton and colleagues [28]
and then known as detergent-resistant membranes (originally coined by
Baird and colleagues [29] based on their insolubility to detergents, in
Table 1
Examples of cell types, raft/cytoskeletal/receptor/channel interactions and raft-regulated cellular functions.
534 B.P. Head et al. / Biochimica et Biophysica Acta 1838 (2014) 532–545particular nonionic detergents at 4 °C [30]), the latter property being at-
tributable to the high content of saturated acyl chains [31,32]. MLR
were termed lipid domains [27] and noted to be enriched in cholesterol,
sphingolipids, and lipidswith saturated acyl chains. These constituents re-
sult in MLR being resistant to membrane disruption by nonionic deter-
gents and having a low density. As a result, one can isolate MLR based
on detergent-resistance and subsequent fractionation on density gradi-
ents [31,32]. Early experiments isolated MLR with 1% Triton X-100
followed by sucrose density gradient fractionation [31]; later studies
employed other detergents including Lubrol, Brij, Nonidet, CHAPS, and
octylglucoside at varying concentrations [14,33]. However, concerns
arose that use of such detergents may produce a ‘false’ clustering of raft
lipids with proteins, interactions that do not exist in cells [33].
Along with techniques used for cell lysis, the method by which rafts
are enriched is just as critical. Song et al. introduced a non-detergent,
high pH (sodium carbonate) isolation method [34], followed by a long
duration (16–20 h) of centrifugation. However, this method introduced
the possibility that “raft fractions” might also include non-MLR mem-
branes. Another approach used an isotonic buffer (0.25 M sucrose) on
a Percoll gradient to isolate PMs followed by a discontinuous gradient
of OptiPrep to generate a much cleaner MLR isolation [35]. Some have
suggested that this methodology produces high variability between
preparations and among cell types [36]. Other techniques include use
of a silica-coating that involves anti-Cav-coated magnetic microspheresto purify Cav-positive PMvesicles fromother detergent-insolublemem-
branes rich in GPI-anchored proteins, but devoid of caveolae [37,38].
Even with this approach, we (and others) caution against potential
discrepancies between varying results based upon different frac-
tionation techniques [30,39]. Membrane puriﬁcation protocols may
also isolate organelles that interact with MLR or the endoplasmic reticu-
lum, whose extensive tubular network can survive cell disruption and
therefore may be falsely considered as organelle impurity [40]. Evidence
is emerging thatMLRmay reside intracellularly in Golgi-endosomal com-
ponents and in vesicular cargos, although in the past, detection of such
structures was considered evidence of lack of purity of MLR [41]. Lysis
buffers that do not sufﬁciently disrupt the cytoskeleton to properly sepa-
rate different species ofMLR (non-caveolar versus caveolar) can also pro-
duce confounding results, especially when performed on cells highly
abundant in cytoskeletal architecture, such as adult cardiac myocytes
[36,42]. Althoughmany types of preparations have contributed to current
understanding of MLR structure and function, their limitations provide a
rationale for the development of improved methodologies that optimize
membrane puriﬁcation and enrichment strategies [33]. For example,
improved fractionation methods in combination with morphological ap-
proaches, such as super-resolution microscopy that allows for ﬂuores-
cence imaging with a precision near 20 nm, may prove useful for
obtaining more consistent and accurate understanding of MLR organiza-
tion and function [43].
Fig. 1. Schematic depicting proposed caveolin monomer structures and oligomer complexes. A, Adapted from Fernandez et al. [80], a model in which the caveolin-1 (Cav-1) scaffolding
domain (CSD) is shown as an α-helix (AA 79–96) with Cav-1 oligomers composed of 7 monomers and an approximate diameter of 11 nm. This proposed heptamer forms because
α-helical lateral interactions proximal to the cytofacial lipid bilayer give rise to a ﬁlamentous assembly 50 nm long. B, An alternative model by Hoop et al. [68] in which the CSD is a
β-strand (red/orange) separated by the wedged shapedα-helix (green barrels) within the cytofacial bilayer by cholesterol (yellow) interacting with a cholesterol recognition/interaction
amino acid consensus (CRAC) motif (blue) with palmitoyl acids (brown strands) anchored to cysteine residues. C, Model byWhiteley et al. [81] in which Cav-3 is arranged with 9 monomers
assembled in a toroidal shape ~16.5 nm in diameter and 5.5 nm in height.
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part as a consequence of disagreements regarding methods for
their isolation and characterization, concerns their existence and bi-
ological relevance [44]. Sincemost of the PM exists in an ordered phase
[45], some suggest a ‘percolating phase’, such that the disordered phase
serves as themicrodomain [46]. This latter theory, while contrary to the
canonical raft hypothesis, may explain clustering of non-raft proteins in
the PM and suggests a bridge between rafts and ‘protein islands’ [47].
Additional studies are needed to help resolve the different notions
regarding plasma membrane organization and MLR.1.2. MLR lipid constituents: sphingolipids and cholesterol
MLR are highly enriched in sterols and sphingolipids. Sphingolipids
are derived from ceramide, a lipid involved in numerous cellular
responses, including differentiation, adherence, migration and cell
death [48–50]. Ceramidewithin the ER is synthesized into sphingolipids
or shuttled to the Golgi complex to become gangliosides (in particular,
GM1 and GM3). GM, which connotes ganglioside plus one (mono)sialic
acid, or GD,wherein theD stands for disialic acid, is a complex glycolipid
with strong amphiphilic properties due to the saccharidic headgroup
and a double-tailed hydrophobic moiety (i.e., ceramide [51]). The
numbers 1, 2, and 3 (e.g., GM1, GM2, or GM3) denote the migration of
the gangliosides on thin-layer chromatography. The presence of sialic
acid distinguishes gangliosides from neutral glycosphingolipids and
sulfatides. Although non-Cav-containing MLR exist in planar forms
that cannot be readily identiﬁed morphologically, MLR can be labeled
with ﬂuorescent cholera toxin (CTX) B subunits, which bind to ganglio-
side GM1 [52,53]. Sphingolipids contain acyl chains that are longer than
the width of a single leaﬂet of the PM [54] and thus, may help facilitate
transmembrane events in the absence of transmembrane proteins.Cholesterol is another major membrane component of MLR. Follow-
ing its synthesis in the ER, cholesterol is trafﬁcked to the Golgi where it
binds sphingolipids or proteins such as Cav [55–59]. These sphingolipid-
and cholesterol-enriched structures self-aggregate in the Golgi and
generate vesicles that are transported to the PM to form MLR. In the
formation of MLR, the sphingolipids associate via their head groups
and cholesterol interdigitates between the sphingolipids [60,61].
Sphingolipids and cholesterol, aswell as GPI-anchored proteins, are pre-
dominantly found in the outer leaﬂets (exofacial domains) of the PM,
while Cav and associated proteins are found in inner leaﬂet (cytofacial)
domains. Cav and other inner leaﬂet proteins interact with membrane
lipids via myristic and/or palmitic acid, which are present on a number
of MLR-localized proteins (e.g., Src and heterotrimeric GTP-binding [G]
proteins). Cholesterol binds certain membrane proteins, such as
G-protein-coupled receptors (GPCRs), and can inﬂuence properties of
GPCRs and presumably other membrane proteins [61].
1.3. MLR scaffolds: caveolin, cavin, ﬂotillin/reggie
Caveolin (Cav), an integral membrane protein that exists in 3
isoforms (Cav-1, -2, and -3), was ﬁrst discovered as a tyrosine-
phosphorylated substrate of Src in transformed chick ﬁbroblasts [62].
This phosphorylation can bemediated by Src, Fyn, Yes, and c-Abl, certain
growth factors, and integrin activation [63]. Cav-1 is also phosphorylated
on serine 80, an event implicated in trafﬁcking of cholesterol [64,65].
Cav-1 contains an α-helical hairpin intramembrane domain (IMD;
residues 102–134) and palmitoylated cysteines 133, 143, and 156,
which are not required formembrane insertion but help facilitate binding
of cholesterol and its transport to the membrane [66] (Fig. 1A). A
cholesterol recognition/interaction amino acid consensus (CRAC)
motif (residues 94–101, VTKYWFYR) within Cav-1 appears to mediate
its binding to cholesterol [67] (Fig. 1B). Cav-1 also scaffolds and
Fig. 2.Membrane/lipid rafts and the endothelium barrier. Schematic depicting different types of MLR and how they serve to regulate endothelial cell (EC) morphology, adherence, and
function. Scaffolding rafts secure the ECs to their surrounding environment [i.e., EC–EC adherence, EC–BL (basal lamina) adherence, and EC–lymphocyte adherence]. Integrins and cellular
adhesion molecules(CAM) work in concert to bind to the extracellular matrix (ECM) and establish the adhesion raftwith underlying BL. Occludins, claudins, zona occludins 1 (ZO-1), and
junctional adhesion molecules (JAMs) form the scaffolding raft of the interendothelial environment. Tetraspanins, caveolins/caveolae, and ICAM/VCAM (inter/vascular CAMs) form a
lymphocyte adhesion raft (LAR), which facilitates lymphocyte recruitment and migration across the endothelium.
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scaffolding domain (CSD) [68,69]. It has been proposed that this 20
amino acid (e.g., amino acid residues 82–101 for Cav-1) CSD is critical
for the binding (via a Cav binding domain [CBD]) and regulation of the
activity of signaling components [12,70], although this proposal has
been questioned [71,72]. Originally thought to be negative regulators
of signal transduction components [69,73], Cavs may also activate cellu-
lar events, including various signaling proteins. Examples include
responses mediated by insulin, Ras, and neurotrophin [74–76]. All
three isoforms of Cav contain a conserved structural motif (FEDVIAEP)
that allows for their oligomerization within a caveolar coat [77], typically
consisting of 12–18 monomers of Cav-1/Cav-2 [78,79] to form a
heteroligomer-ﬁlamentous structure [80]. Recent data suggest that 9
monomers can form a homoligomer-toroidal shape for Cav-3 [81] and
for the CSD (Fig. 1C).
Since Cav exists in cells that lackmorphological caveolae [12,82], this
raises the question: what causes these unique plasmalemmal invagina-
tions? Recent evidence has shown that caveolar formation appears to
depend upon the protein cavin (also known as polymerase I and tran-
script release factor, PTRF [83]). There are 4 isoforms of cavin: cavin-1
(PTRF), cavin-2 (aka serum deprivation protein response [SDPR]),
cavin-3 (aka sdr-related gene product that binds C-kinase [SRBC]), and
cavin-4 (aka muscle restricted coiled-coil protein [MURC]) [84]. Cavin
is a peripheral membrane protein that binds to phosphatidylserine
within caveolae [85]. Cavin and Cav exist in a 1:1 stoichiometric ratio
in caveolae in close proximity with each other [86]. Cavin is phosphory-
lated on serine residues 36, 40, 365, and 366 [85], possibly by the serine/
threonine kinase ARAF1 [77]. Cavin appears to be essential for caveolar
invagination, i.e. for the formation of morphologic caveolae. Another
family of proteins that have been described in MLR are ﬂotillin-1/
reggie-2 and ﬂotillin-2/reggie-1, which were originally discovered as
neuronal proteins in retinal ganglion cells during regeneration after
injury [87,88]. Flotillins/reggies oligomerize via their C-terminal taildomains [89] and have been implicated in the endocytosis of GPI-
anchored proteins. The planar formofMLR ranging 1–1000 nm in diam-
eter is enriched in GPI-anchored proteins and in ﬂotillins. By contrast,
caveolae have a diameter of 70–120 nm [25,90].1.4. Receptor activation and MLR clustering
Planar and caveolar MLR can bind proteins. Although no speciﬁc
amino acid sequence or motif has been identiﬁed that targets a
particular protein to MLR, certain post-translational modiﬁcations such
as glycosylphosphatidylinositol (GPI)-anchors, palmitoylation and
myristoylation appear to help localize proteins to MLR [91]. One
observes a high variability of membrane domains and MLR abun-
dance in different cell types and the MLR can vary in their content
of cholesterol and expression of caveolin, which, in turn, inﬂuences
MLR abundance and function, including in their localization/enrich-
ment of certain membrane proteins, such as signaling receptors [92].
MLR can exist as clusters; alternative models propose that 1) non-
MLR receptors translocate into MLR upon ligand binding leading to
signal transduction or 2) spatially separate MLRs cluster to one an-
other only after ligand binding and receptor activation [93]. Other
models propose that clustering can occur via inner leaﬂet interac-
tions (facilitated by ﬂotillins, Cavs, and annexins) or outer leaﬂet
clustering through GPI-anchored proteins. Clustering of MLR can
alter their function, for example, creating signaling platforms
[10,94,95]. Caveolae can undergo endocytosis (via dynamin-II) to
become intracellular organelles, termed caveosomes [96], which in-
ﬂuence functional activities, such as in mechanotransduction to
modulate blood ﬂow and vascular tone [97]. Although the model
proposed by Gowrishankar et al. [24] demonstrates that lateral
membrane clustering of microdomains depends upon cholesterol,
sphingolipids, and an active actin/myosin network, this model can
Fig. 3.Membrane/lipid rafts and the epithelium barrier. Schematic illustrating the role of membrane/lipid rafts (MLR) in epithelial apical–basal polarity. MLR form unique plasmalemma
outward (cilium andmicrovilli) and invaginations (deep tubules). MLR and associated scaffolds also establish tight junctions (TJ), adherent junctions (AJ), gap junctions (GJ), tetraspanin-
enriched microdomains (TEM), caveolin-enriched microdomains/caveolar membranes. Scaffolding and cholesterol-binding proteins such as caveolin and prominin as well as junctional
adhesionmolecules (JAM), zona occludins (ZO), cadherins, and connexins all participate as signaling platforms, sites for intercellular adherence and for actin cytoskeletal tethering in order
to create a barrier from the outside environment but also regions that deliver molecules, nutrients, and ions into cells and ultimately to host organisms.
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membranes that lack sterols, such as in Caenorhabditis elegans [98].1.5. Cellular polarity: endothelium and epithelium as examples
Amonolayer of endothelial cells (endothelium) lines the vasculature
as an initial barrier between bloodborne components (e.g., oxygen,
nutrients, cells) and tissue parenchyma. Caveolae are higher in abun-
dance in lung vascular endothelial cells than in any other mammalian
cell type [99]. Caveolae concentrate proteins involved in vesicular
trafﬁcking (i.e., formation, ﬁssion/fusion, and docking), aswell as signal-
ing receptors that include receptor tyrosine kinases (RTK), GPCRs, G
proteins and downstream enzymes such as adenylyl cyclases (ACs)
and endothelial nitric oxide synthase (eNOS, NOS3), all of which
co-localize with Cav-1 in caveolae of endothelial cells (Fig. 2). In addi-
tion, endothelial caveolae sense alterations in shear stress and help
mediate mechanotransduction in response to blood ﬂow, i.e. changes
in vascular contractile tone and reactivity to various stimuli. Caveolae
also contribute to intracellular calcium and redox signaling, andmacro-
molecular transcytosis in endothelial cells [100].
Numerous processes contribute to lymphocyte adherence and
migration across the endothelium [101]. In order to facilitate lympho-
cyte activation and migration, the endothelial PM works in concert
with theunderlying cytoskeleton [102,103].Many lines of evidence sug-
gest that lipid reorganization occurs during this event, which affects
MLR dynamics and in turn, the recruitment of key adhesion molecules,
junctional proteins, and transporters. This apical PM re-organization
works in concert with the underlying actin cytoskeleton to mediate
the morphological changes needed for lymphocyte migration [15,104].
Some studies suggest that this interaction occurs between adhesion
molecules such as cadherins and the actin cytoskeleton via catenins
after a series of events regulated by Rho GTPases [102,103]. MLR also
organize additional components that facilitate intercellular adhesion
and integrity to initiate leukocyte transcellular transport and events
such as AMPKa1 activation, cadherin signaling [105,106] and transportof low-density lipoproteins and chemokines across the microvascula-
ture [107,108].
Endothelial cell Cav-1 in MLR regulates other events involved in
endothelial cell polarity and barrier function [109], including nitric
oxide production/signaling and Src phosphorylation [110], Cav-1
and eNOS-mediated activation of p190RhoGAP-1[111], and Cav-1
regulation of TRPC1 (transient receptor potential cation channel 1), IP3 re-
ceptor signaling and calcium entry (via Ca2+ store release-induced Ca2+
entry) [112]. In addition to NOS signaling pathways [113], other effector
enzymes (e.g., AC) as well as actin binding proteins, such as ﬁlamin,
contribute to endothelial barrier function in a Cav-1 dependent manner
[105].
Interactions of caveolae with cytoskeletal components regulate
endothelial trafﬁcking and endocytosis. Caveolae are closely associated
with actin ﬁbers and can internalize membrane vesicles to Rab11
endosomes [114]. Actin-binding proteins such as ﬁlamin A facilitate
Cav-1 internalization in a PKCα-dependent manner during cellular
detachment. Other data show that caveolar endocytosis is controlled
by actin; Src-induced phosphorylation of Cav-1 increases the associa-
tion of ﬁlamin A with Cav-1 and subsequent caveolar-mediated
transport and vesicular internalization [115]. Regulation of caveolar
endocytosis can also occur by intersectin 2L, a guanine nucleotide
exchange factor for the Rho GTPase Cdc42 [116]. Thus, the regulation
of actin cytoskeletal-mediated endocytosis depends upon Cav-1, at
least in part, by its post-translational modiﬁcations.
Epithelial cells provide an interface between an organism and its out-
side environment and regulate entry of ions and nutrients. The apical
membrane of epithelial cells contains MLR that are enriched in α- and
β-integrins that adhere to components of the ECM (including collagen,
laminins, ﬁbronectin) and that communicate with the actin cytoskele-
ton via talins, paxillin, and focal adhesion kinase (FAK) [117,118]
(Fig. 3). MLR clustering of signaling complexes is crucial for formation
of apical membrane microdomains that have GM1 within microvilli
and in basal membranes and GM3 at the apical base [119]. Such MLR
contain proteins that include prominin, a cholesterol-binding pentaspan
glycoprotein [120] and Cav-1. Cav-1 is necessary for a variety of types of
Fig. 4.Membrane/lipid rafts, growth cone advancement and axonal guidance. Series of schematics depictingMLR (red PM) at the leading edge of a neuronal growth cone. This polarity and
forwardmigration of the axonal growth cone cannot occur withoutMLR and the underlying actin (blue) and tubulin (green) cytoskeleton. Inset A shows a closer illustration of the growth
cone with MLR at the leading tips receiving extracellular guidance cues and also tethering and transducing those cues to the ﬁlamentous (F-) actin. The axonal microtubule (MT)-associated
protein Tau cross-links adjacent MT to maintain axonal integrity and facilitate guidance. Inset B shows a close up of several important MLR signaling receptors and enzymes (AMPAR, Trk,
SFK, Rho GTPases), scaffolds (caveolin, ﬂotillin, tetraspanin), and adhesionmolecules (integrins, NCAMor neuronal cellular adhesionmolecule). F-Actin binding proteins such as ﬁlamin anchor
F-actin to MLR scaffold proteins.
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with protein components of tight, gap, and adherent junctions (TJ, GJ,
AJ) [121]. Cav-1 interacts with claudins and occludins in apical and lateral
membrane MLR. These polarized membrane regions are necessary for
restricting paracellular transport and depend upon actin–alpha actinin
interactions. Within AJ zona occludins establish links to the tubulin-
based cytoskeleton, as well as actin; Cav-1 appears to be necessary for
retrieval of these junctional proteins [122]. Caveolar-type MLR are also
involved in endocytosis by epithelial cells [123], which in some instances
involves Rab11 and the tubulin-based cytoskeleton [124]. Additionalﬁnd-
ings indicate that basolateral membranes may contain different Cavs
[125,126] and lipid components [127,128] than those of the apical mem-
branes of epithelial cells. These differences in protein and/or lipid compo-
nentsmay contribute in part to the distinct polaritieswithin the same cell.
1.6. MLR–cytoskeletal tethering: migration and mechanotransduction
PM signaling platforms facilitate ECM adhesion and cytoskeletal
tethering to themembrane. These interactions are necessary for cell mi-
gration, especially in the setting of tissue remodeling, and require polar-
ized signaling complexes within MLR and actin components [129]. Forexample, MLR–actin interactions lead to pseudopod protrusion and
phagocyte migration following nucleotide-mediated chemotaxis [130].
Cav-1 is involved in endothelial migration, organizing pro-angiogenic
signaling components with MAP kinases, Src and TNF receptor-
associated factor 6 [131]. In the brain, Cav-1 is phosphorylated in
podosomes that permit microglial invasion, a migratory mechanism
similar to that exhibited by invadosomes in peripheral tissues [132].
While some cells use MLR to facilitate signaling between the ECM and
intracellular cytoskeletal components and as a result, induce morpho-
logical changes necessary for detachment and migration, other cells
use such platforms to cause contraction. For example, lymphocyte
mechanotransduction occurs through stretch-activated cation channels
and subsequent actin rearrangement in MLR [133,134], while endothe-
lialmechanotransduction depends in part upon integrin/P-Cav-1 signal-
ing events [63,97,135].
Localization of receptors and channels in MLR helps regulate cyto-
skeletal events necessary for contraction of smooth and striated muscle
myocytes [136–138]. In the heart, contraction of cardiac myocytes leads
to cardiac emptying and is initiated by themovement of ions across the
plasma membrane (sarcolemma) via several types of ion channels
[i.e., K+, KATP, KCa, TRPC channels, voltage-gated Ca2+ channels,
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3-enriched MLR. Cav-3 scaffolds the β-adrenergic receptor-Gαs-AC sig-
naling cascade, contributing to the generation of cAMP [42,140]. In addi-
tion, Cav-3 interactswith the sarcoplasmic reticulumCa2+ channel, RyR,
which upon activation, increases Ca2+ release into the cytosol [141].
Caveolae also organize other cardiac myocyte receptors, G proteins,
channels, and actin binding components [13,142–145] and proteins
that mediate cell–cell adherence [146].
Skeletal muscle contraction depends upon Cav-3-enriched MLR and
interactions with cytoskeletal components. For example, depletion of
cholesterol from skeletal myocyte membranes disrupts β-dystroglycan
interaction with Cav-3 and weakens contraction [147]. Akin to what
occurs in cardiac myocytes, Cav-3 forms microdomain complexes with
RyR and VGCC in transverse tubule membranes in addition to ones
with other Ca2+ channels [148], interactions that regulate Ca2+ ﬂux
and excitation–contraction coupling [137,149]. Cavs also organize ion
channels (e.g., TRPC, K+, Na+ and Ca2+ channels) and interact with
cytoskeletal components involved in smooth muscle contraction and
vascular tone [150–153].
1.7. Neurons: implications for pro-growth signaling and neuronal
membrane repair
Many studies have examined factors that promote neuronal devel-
opment and regeneration, especially in the setting of injury or
neurodegeneration. The neuronal membrane, in particular neuronal
MLR, is critical for the initiation of growth in response to extracellular
cues. This role derives from the organization in MLR of complexes in-
volved in cellular polarity and pro-survival and pro-growth receptor
signaling necessary for neuronal sprouting (Fig. 4). Accumulating evi-
dence indicates that pre- and post-synaptic proteins essential for neuro-
nal communication localize to MLR [93]. The localization of receptors,
proteins, and signaling molecules to MLR partially depends uponFig. 5.Membrane/lipid rafts and the immunologic synapse. Panel A, or pre-activation state, dep
themajor histocompatibility complex (pMHC) to the T cell receptor (TCR) locatedwithinMLR lo
cell adhesionmolecules (integrins) locatedwithin tetraspanin-enrichedmicrodomains (TEMs)
state, shows that after TCR–pMHC interactions, the pSMACMLRmigrates laterally towards the
through subsequent TCR downregulation.scaffolding and cholesterol binding proteins such as Cav-1, ﬂotillin-2
(Flot-2), and tetraspanin-7 (TSPN-7) [76,154,155]. Examples include
GPCRs, RTKs, ion channels, G proteins, ACs and RhoGTPase familymem-
bers, which have been shown to be clustered together by Cav-1 and
Flot-2, thereby facilitating high ﬁdelity signaling involved in the regula-
tion of neuronal responses. However, in addition to scaffolding proteins,
the coalescence of smaller scale MLR into a larger rafts through lateral
membrane distribution can also occur due to a lipid–lipid or protein–
lipid interaction. These events induce cholesterol enrichment and also
lead to recruitment of transmembrane, exofacial and cytofacial lipid-
anchored proteins [156]. The lateral distribution of these rafts into clus-
ters can be stabilized due to their afﬁnity for existing raft domains; such
interactions can enhance the segregation of those components with
weak MLR afﬁnity (i.e., transferrin receptor) [156].
MLR are at the leading edge of growth cones and promote neurite
extension and subsequent axonal guidance [157–160]. Disruption of
MLR perturbs their interaction with microtubule proteins and causes
neurite retraction [17]. In addition to receptors and ion channels, cyclic
nucleotides are involved in growth of neurites: cAMP promotes axonal
growth and inhibits dendritic growth while cGMP promotes dendritic
growth and inhibits axonal growth [161]. The cAMP effector Epacmedi-
ates cAMP-promoted axonal attraction, while cAMP acting via PKA
induces axonal repulsion [162]. Although more work is needed to iden-
tify if distinct cyclic nucleotide ‘pools’ promote neurite growth and
axonal/dendritic guidance that originate from neuronal MLR, AC8, a
neuron-speciﬁc isoform, localizes to MLR, and can tether the actin cyto-
skeleton to rafts [163]. Evidence does not yet exist for Cav-1/AC 8 inter-
actions in neuronal MLR but Cav-1 and membrane cholesterol can
regulate a variety of neuronal receptors and channels (e.g., VGCC that
promote cAMP production and Ca2+ signaling [76,164]).
Cav-1 has a direct effect on various neuronal receptors. Cav-1 en-
hances NMDAR-Src signaling and neuroprotection while loss of Cav-
1 blunts the ability of NMDAR-Src to protect from oxygen/glucoseicts an antigen presenting cell (APC) that is presenting peptide antigens extracellularly via
cated in the central supramolecular activation cluster (cSMAC). APC and T cells connect via
located in the peripheral supramolecular activation cluster (pSMAC). Panel B, or activation
cSMAC via actin cytoskeletal rearrangement. cSMAC regulates termination of the signaling
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AMPAR signaling and turnover [82] and mGluR signaling and inter-
nalization in hippocampal and striatal neurons [82,167–169]. Cavs
have also been implicated in the effects on membrane estrogen re-
ceptor (ER) signaling in neurons [168]. While there is evidence that
Cav-1 promotes crosstalk between ERα and mGluR1, the “muscle
isoform”, Cav-3, mediates ERα/ERβ crosstalk with mGLuR2/3 [170].
It remains to be determined whether this cross-talk results from
cytoskeletal-mediated clustering of MLR or from neurotransmitter
signaling and changes in membrane conductance. Neurons lackmor-
phologic caveolae but Cav isoforms andMLR seem to regulate synap-
tic receptors, channels, and components of the actin cytoskeleton,
which in turn facilitate neuronal growth and arborization [76].
Besides Cav, other MLR scaffolding proteins (e.g., Flot-2 and TSPN7)
and lipids (e.g., gangliosides) contribute to the organization of neuronal
signaling components that regulate synaptic function and plasticity
[154,155]. As noted above, Flot is a cytofacial leaﬂet scaffolding and cho-
lesterol binding protein that is up-regulated in regenerating optic nerve
axons [154]. Flot clusters prion proteins (PrP) and amyloid precursor
proteins (APP) at the membrane prior to clathrin-dependent endocyto-
sis [171]. Flot contributes to the clustering of the tyrosine kinases Src,
Fyn, and Lck in addition to Rho-GTPases (e.g., Rac, Rho, and Cdc42)
into active signaling platforms, potentially facilitating axonal regenera-
tion [172–175]. Flots also localize proteins, such as adhesion molecules
(e.g., cadherins and integrins) and FAK, to the leading edge of neurites;
such proteins help alter the cytoskeletal organization required for
neuronal growth. More recent work has demonstrated a physical asso-
ciation of MLR with neuronal membrane postsynaptic densities, which
included cytoskeletal (actin) and cytoskeletal-binding components
such as drebrin, fodrin, shank, and homer [14]. Along with Cav-1 and
Flot, TSPN-enriched MLR are also critical for neuronal growth [155].
TSPN7 promotes ﬁlopodial and dendritic spine formation in hippocam-
pal neurons through interactions with the PDZ domain of PICK1
(protein interacting with C kinase 1), GluR2/3, and AMPAR. TSPN7 reg-
ulates PI4K type II activity and its association with actin ﬁlaments, facil-
itates β1-integrin recruitment, and modulates AMPA receptor currents
and trafﬁcking, which is crucial for synaptic plasticity, learning and
memory [176]. Non-protein components of MLR, such as gangliosides
and cholesterol, activate the pro-growth neurotrophin signaling recep-
tor TrkA and promote interaction with microtubules and thereby,
axonal growth [177,178]. Because MLR-associated components (Cav,
Flot, gangliosides, cholesterol) are up-regulated and appear to be
required for axonal growth and regeneration, interventions that
enhance MLR formation in neurons may be a novel therapy following
spinal cord or brain injury. In addition, as the cytoskeleton appears to
be a key element of maintenance of MLR, cytoskeletal stabilization
may offer a second therapeutic approach.
1.8. MLR and the immunologic synapse
Many factors initiate inﬂammatory responses to entities that include
microorganisms, antigens and foreign bodies. Responses of the immune
system are initiated by extracellular cues tomembrane-localized signal-
ing complexes. The organization of receptors, channels, and effector en-
zymes inMLRof immune cells is an important aspect of these responses.
Within MLR, cholesterol, sphingolipids, and the underlying cytoskele-
ton play an essential role in communication of immune cells (Fig. 5).
What have been termed “immunologic synapses” are formed by the
presentation of an antigen from the antigen presenting cell (APC) to
the T cell. In this process, peripheral MLR cluster towards a central
MLR region to become a supramolecular activation cluster (cSMAC);
this clustering and T-cell antigen receptor (TCR) activation (i.e., its
dimerization) is cholesterol-, sphingomyelin-, and Cav-1-dependent
[179,180]. MLR–cytoskeletal interactions are essential for T cell activa-
tion [181–183]. The lateral membrane mobility and clustering of MLR
are thought to enhance signal transduction at immunologic synapses.This clustering depends upon Rho-mediated actin rearrangement;
disruption of rafts prevents formation of immunologic synapses [10].
Within MLR, Cav-1 contributes to membrane polarity and TCR-
induced actin polymerization of CD8 [180]. In addition, CD26 binds
Cav-1 in APCs to induce T cell proliferation in a TCR/CD3-dependent
manner [184].
In addition to Cav, theMLR-associated proteins Flots and TSPNs play
a role in T cell activation. Flot in polarized regions of T cells forms a ‘cap’
where TCR complexes organize following stimulation [154]. This ‘cap’ is
necessary for T cell activation in that it localizes the TCR and initiates
communication with actin through Fyn, Lck, Src, and Rho GTPases. Sim-
ilar to subcellular actions exhibited in neurons, Flots interact with the
GPI-anchored protein PrP to form PrP clusters and subsequent recruit-
ment of CD3. TSPNs facilitate similar clustering events and regulate
the lateral movement of SMAC, leading to the formation of cSMAC in
an actin-dependent manner following TCR activation and CD3 chain
phosphorylation by Lck [185,186].
Certain other functions of blood cells are dependent upon MLR/
cytoskeletal interaction. For example, MLR are involved in erythroblast
enucleation in a Rac-microtubule dependent manner [187]. Platelet
interaction with damaged endothelial regions is dependent in part on
the anchoring of glycoprotein GPlb-IX-V complex to MLR via interac-
tions with ﬁlamin and the actin cytoskeleton [188]. Moreover, platelet
activation is dependent upon PrP localization to MLR and interactions
with the platelet cytoskeleton [189].
1.9. MLR and disease: entry of pathogens and toxins, migration of
malignant cells and Alzheimer's disease
1.9.1. Pathogen invasion
Endocytosis plays an important role in the communication between
eukaryotic cells and their outside environment by regulating cell
dynamics and homeostasis. Cytoskeletal rearrangement allows (and is
required for) cellular entry via MLR of many types of cargo, including
nutrients, receptor–ligand complexes, lipid, antigens, DNA nanoparticles,
and infectious agents that include fungal, bacterial, and viral pathogens
[190–195]. Of note, especially with respect to disease, are the roles of
MLR and interaction with cytoskeletal components in the endocytosis of
microbial-derived toxins and pathogens. One example is the neurotropic
fungal pathogen Cryptococcus neoformans, which crosses the blood brain
barrier of brainmicrovascular endothelial cells via aMLR-mediated endo-
cytotic pathway [192]. This occurs in GM1-enriched regions and is regu-
lated by dual speciﬁcity tyrosine-phosphorylation-regulated kinase 3
(Dyrk3) [192]. Pore-forming toxins such as equinatoxin II invade cells
by binding to MLR, and subsequently re-organize the actin cytoskeleton
to facilitate toxin entry that leads to cell death [94]. As part of their inva-
sion of cells, bacterial toxins such as the exotoxin of Vibrio cholerae, CTX
and Shigella dysenteriae Shiga (STX) bind to the MLR glycosphingolipids
GM1 and globotriasylceramide Gb3, respectively [194]. Such toxins
(which also include Shiga-like toxin, Escherichia coli Heat labile entero-
toxin 1 and Heat labile toxin IIb) are composed of a catalytic A subunit
and a pentameric B subunit; the latter ﬂat-like ring structure binds to
the carbohydrate moiety of glycosphingolipids to achieve internaliza-
tion. Clostridial neurotoxins, such as Tetanus and Botulinum, possess a
single binding subunit and invade cells by binding to gangliosides
GT1b, GD1b, GQ1b, GD1a, and GT1b [196,197]. Several types of viruses
utilize glycosphingolipids (MLR) for eukaryotic cell invasion; examples
include Simian virus 40, murine, Merkel cell and BK polyomavirus, and
murine norovirus [194].
1.9.2. Cancer cell metastasis
Migration of metastatic cells and their invasion of tissues depend
upon many cellular events, including detachment from adhesion mole-
cules [198]. MLR-resident proteins at focal adhesion sites play a central
role in initiating detachment from the ECM [158]. For example, prostate
cancer cells appear to require Cav-1, cavin-1, Src, FAK, and the actin
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components [199–201]. In some cases MLR proteins (e.g.,Cav-1) are
released by these cells, an event that alters recruitment of the actin
cytoskeleton to the PM [202]. MLR also contribute to the regulation of
polarized cell adhesion through growth factor receptor activation in a
ligand-independent manner [203], via CD24-integrin-mediated
transmission of contractile forces [204], or as a platform for associa-
tion of the KCl cotransporter with a myosin–actin motor protein
[205]. Neuroblastoma/glioma cell migration may occur, at least in part,
through the action of MLR-localized P2Y2 receptor-Gq/11-PLC signaling
[206].
1.9.3. Neurodegenerative diseases
MLR play contrasting roles (i.e., preventive or exacerbating) in
certain neurodegenerative diseases, such as Alzheimer's disease
(AD). Altered MLR homeostasis or “lipid raft aging” has been sug-
gested to be a factor in the processing of amyloid precursor protein
(APP) to the toxic amyloid beta (Aβ) peptide [207–210]. Enhanced
phospholipid/cholesterol ratios are found in brain membranes from
AD mice compared to those of wild-type animals, suggesting that
“lipid raft aging” results from alterations in the structure and physi-
cochemical properties of raft microdomains [208,211,212]. Within
MLR, both Cav-1 and Flot have been implicated in AD, in particular
with regard to γ-secretase-mediated APP processing [210] and
estrogen receptor-voltage-dependent anion channel (VDAC) neuro-
protection [209]. However, it is unclear if these raft proteins enhance
or dampen the production of the neurotoxic peptides [210,213].
Thathiah et al. have demonstrated that a GPCR–β-arrestin 2 interac-
tion in MLR enhances γ-secretase activity and subsequent genera-
tion of Aβ peptide and that GPCRs enhance Aβ production through
their association with β-arrestin 2 in MLR [214]. Aβ production can
alter membrane mechanical properties, such as membrane ﬂuidity
and molecular order [215], suggesting that alterations in physio-
chemical properties of the PM may be the result of Aβ aggregates
rather than the cause of such alterations.
Alterations inMLR integrity due to oxidative stress [216], changes in
lipid bilayer components that lead to alteredMLR physiochemical prop-
erties [217] or depletion in membrane cholesterol content [218,219],
not only alter cellular polarity [220], signal transduction [221], andmor-
phology, but also can contribute to aberrant intercellular communica-
tion leading to organ pathology, including in the nervous system
[166,222,223].
A general conclusion of work to date (in the nervous system and
others) is that expression of MLR in animal cell membranes depends
upon sterols, sphingolipids, and an active, energy-dependent actin/
myosin meshwork. This dependency on cellular energy implies a
role for mitochondria in close proximity to the MLR/cytoskeletal in-
teraction. Studies are needed to investigate mitochondrial transport
[224,225] and how mitochondria that are closely apposed to rafts in
the PM interact with the actin/myosin-containing components
[226]. Data from such efforts should further our understanding of
normal cell physiology and how disease, injury or oxidative stress af-
fects MLR clustering, signaling, and cell function or fate both within
and outside the central nervous system.
2. Conclusion
MLR are involved in numerous cellular functions, which include sig-
naling, trafﬁcking, adhesion, migration, and growth—all of which may
involve an interaction between rafts and the actin/myosin and tubulin
cytoskeleton. Certain components that regulate actin polymerization
and can stabilize microtubules are associated with membrane rafts
(e.g., Src family kinases and small Rho GTPases). Considerable
data show that microtubules and the actin cytoskeleton are intimately
associatedwithMLR. This association contributes to cytoskeletal organi-
zation and recruitment of ‘cargo’ to the PM, which in turn facilitate cellpolarity, adherence and migration, stretch and contraction, and the
transduction of extracellular signals to the intracellular milieu.
MLR facilitate the assembly of cell-surface proteins and signaling
‘hubs’ at the PM. These signaling platforms communicate with
the cytoskeleton (via small GTPases) so as to facilitate the transport
and recruitment of bulk membrane material (i.e., lipids and
proteins) from internal vesicular stores to MLR and likely to other
portions of the PM. “Clustering” of proteins helps establish polarized
platforms necessary for ECM adhesion, cellular migration, mem-
brane growth, expansion or guidance (ﬁlopodia, neuritic processes),
and in the case of smooth and striated muscle, mechanotransduction
(stretch and contraction/relaxation). Within MLR, receptors, chan-
nels, and small GTPases can communicate with high ﬁdelity, interac-
tions that occur, at least in part, as a consequence of their close
proximity to one another.
Extracellular stimuli that trigger membrane signal transduction,
protein recruitment, and alterations to the cytoskeletal architecture,
depend upon MLR integrity and function. Signaling and activation of
small GTPases to regulate actin dynamics are regulated by the presence
of protein scaffolds such as Cavs, reggies/ﬂotillin, GPI-anchored proteins,
and tetraspanins. These protein scaffolds contribute not only to the
formation of membrane microdomains but also to the lateral clustering
of microdomains within the PM (e.g., tetraspanin-enriched integrin do-
mains clustering with TCR-enriched liquid ordered nanodomains)
and thereby, help facilitate high ﬁdelity extracellular–intracellular sig-
naling, especially via cytoskeletal components. The clustering of lipids
and proteins forms this signaling platform.
Although the precise properties and functions of MLR in the resting
state of the PM remain incompletely understood (and controversial), a
role for liquid-ordered domains in signal transduction, and actin-
containing cytoskeletal components in the formation of larger function-
al MLR via clustering of nanoscale membrane domains is more widely
accepted [30,227]. Signaling enhances MLR clustering into a centric or
focal region of the cellular membrane, thus leading to the question as
to whether MLR enhance signaling or if initial signaling events enhance
MLR formation and clustering. Irrespective of the answer to this
“chicken–egg” question, the interplay betweenMLR-associated proteins
and the cytoskeleton impacts on cellular signal transduction, polarity,
and morphological changes. Advances in understanding the biology
and chemistry of MLR (for example, the precise identity and functional
role of the full complement of lipids and proteins in MLR from different
cells) and how they are intimately connected with the ECM and under-
lying cytoskeleton should provide new insights regarding cellular
communication and regulation. Other questions remain as well. For
example, do different subcellular MLR species regulate membrane
functional properties via differences in assembly and interaction of
components within the same cell (e.g., apical versus basal membrane
formation in epithelial and endothelial cells or axonal versus dendritic
neuritic conversion in neurons)? Is there a common pattern within
different cell types with respect to the cytoskeletal components that
interact with MLR? Are MLR therapeutic targets? We believe that ﬁnd-
ings related to MLR may have therapeutic implications, for example by
identifying components to which therapies could be developed (for
example, cell-type-speciﬁc targeted overexpression of proteins,
microRNAs (miRs), antagomirs) or ones that are modiﬁed to restore,
maintain or repair membrane raft integrity and function in diseased
or injured cells and tissues.Acknowledgements
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